New research appearing in the Journal of the National Comprehensive Cancer Network found that incorporating information from ...
The Prostate Cancer Foundation (PCF) today announced $6.3 million in funding for 31 exceptional Young Investigators pursuing ...
For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer. The research lays a foundation for the possibility that aggressive prostate cancer can ...
A trial evaluated the short-term oncologic efficacy of cooled focal therapy ablation using the ProFocal device in men with localized, intermediate-risk prostate cancer.
– 32nd Annual Scientific Retreat brought together 600+ prostate cancer researchers and leaders to spotlight breakthrough discoveries and advance cutting-edge science – – PCF continues to be the ...
By KATRINA BRANDON DONATIONS have opened up opportunities at Latrobe Regional Hospital (LRH) thanks to Latrobe's Biggest Ever ...
Vipul R. Patel, MD, FACS, is a board-certified urologic surgeon, medical director of the Global Robotics Institute at AdventHealth, and medical director of urologic oncology at AdventHealth Cancer ...
A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...
Reliable information and advocacy efforts empower kidney cancer patients to engage in research and treatment decisions. Pluvicto's FDA approval provides a new treatment for PSMA-positive metastatic ...
News-Medical.Net on MSN
PSMA PET/CT scans may predict prostate cancer recurrence, guide treatment
New research in the February 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans ...
World Cancer Day collaboration supports clearer, more inclusive access to cancer clinical trials By hosting the ...
UCLA researchers found that routine PSMA PET/CT scans could help doctors select treatment approaches for the best long-term outcomes in patients with recurring prostate cancer after surgical removal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results